Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Pietrusko, Amy Schulman, Frank Slack

Premium

Voyager Therapeutics has appointed Robert Pietrusko as its senior vice president of regulatory affairs.

Pietrusko most recently served as vice president of global regulatory affairs and quality at ViroPharma prior to its acquisition by Shire. Before that, he was senior vice president of worldwide regulatory affairs at Millennium Pharmaceuticals.


Alnylam Pharmaceuticals has elected Amy Schulman to its board of directors.

Schulman is the former executive vice president and general counsel of Pfizer, where she also was the business unit lead for its consumer healthcare business. She currently is a senior lecturer at Harvard Business School.


Frank Slack has been appointed as the director of the Beth Israel Deaconess Medical Center's Institute for RNA Medicine, which was launched this month to foster research into the use of RNA to treat cancer and other diseases.

Slack was previously at Yale University, where he conducted key microRNA research.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.